New Cannabis Information Line Launches in Canada

Published: August 26, 2020

New Cannabis Information Line Launches in Canada

 Starting today, a new cannabis information line will be available to all Canadians. Designed by doctors, Cannalogue’s CBDHelp is a free telephone information line for individuals or caregivers looking for general guidance on medical cannabis including recommended uses and applications for cannabidiol (CBD). Staffed by medical professionals, CBDHelp was developed by Cannalogue as a way to help better educate consumers about the potential benefits of medical cannabis in treating a variety of conditions including anxiety, stress, difficulty sleeping, gastrointestinal issues and chronic pain, among others.

“We launched CBDHelp in response to the growing number of inquiries we were receiving about how and when to use medical cannabis,” said Dr Mohan Cooray, President and CEO of Cannalogue. “There continues to be a tremendous amount of misinformation and stigma associated with cannabis use and we wanted to help Canadians understand the benefits of cannabinoids such as CBD as an alternative to harmful and often addictive pharmaceutical therapies,” he says.

CBDHelp is available Monday-Friday from 9am – 5pm EST by calling toll free at 1-833-CANNA-4-U (1-833-226-6248). Call backs can also be arranged through the Cannalogue website at www.cannalogue.ca/cbdhelp.

Based in Toronto, Cannalogue is a rapidly emerging healthcare technology company that received Health Canada’s first direct-to-sales licence for medical cannabis. Cannalogue’s innovative technology provides a safe, controlled, and cost-effective online marketplace that is globally scalable into all medical cannabis markets. Engineered by physicians, Cannalogue challenges the status quo and advocates on behalf of patients to educate medical professionals and government officials on the safety and benefits of medical cannabis as a viable treatment option to traditional therapies.

Recent News

View All News Items

Latest Article

Characterizing the Cannabis Experience of the Surreal High Sun Mint Lime Fizz Beverage Using Cognalyzer® EEG

Characterizing the Cannabis Experience of the Surreal High Sun Mint Lime Fizz Beverage Using Cognalyzer® EEG

Herein, Zentrela scientifically characterized the unique cannabis experience created by the SURREAL High Sun Mint Lime Fizz beverage in study subjects. The SURREAL High Sun Mint Lime Fizz beverage contains 10mg of THC, 0mg of CBD, 10mg of CBG, and various non-cannabinoid ingredients such as 4g of sugar and lime juice concentrate, among others.  Through the execution of this study, Zentrela determined the onset time and maximum potency of the psychoactive effects induced by this specific product. Additionally, we quantified significant mood changes potentially associated with the consumption of this beverage.

Read Article